The Medicare Part D marketplace continues to shift in ways that bear deep impact on managed care companies, pharmaceutical manufacturers, policymakers, and people who rely on the drug benefit for their prescription drugs.  Changes for 2008 reflect important trends that have broad business, clinical, and consumer implications.  Competition within the market is intensifying as plans push to maintain customer loyalty and achieve profitability. 

Using its proprietary DataFrame® database, Avalere Health analyzed many aspects of nearly 4,500 Medicare drug plans offered in the 2008 marketplace.  Avalere’s analytics will help you:  

• Understand the Commercial Response to the 2008 Medicare Marketplace
• Study Contrasting Commercial Strategies and Plan Structures
• Observe Choices Facing Medicare Beneficiaries
• Evaluate Trends and Developments from 2006-2008

Commercial Health Plans, Pharmaceutical and Biotechnology Experts, Healthcare Investors, Consumer Groups, State and Federal Policymakers, Health Policy Analysts, Research Organizations, and Advocacy Organizations

		PDF $5,000 (Price includes Parts 1 and 2. Part 2 forthcoming, Nov 2007.) * Volume discounts available
Copyright 2007 Avalere Health LLC. All rights reserved. Reproduction, distribution, or quotation in whole or part without permission is strictly forbidden.

For questions, please contact: Melicia Seay at 202.207.3463, or at mseay@avalerehealth.net.

Register for our November 29 audio conference on “Evolution in the Medicare Marketplace.”